Paris, France, April 10, 2026 (GLOBE NEWSWIRE) — Matricis.ai, a healthcare know-how firm creating synthetic intelligence options for gynecological imaging in a world ladies’s imaging market estimated at greater than $5.2 billion, right now introduced a scientific collaboration with SimonMed Imaging, one of many largest outpatient imaging suppliers in the USA. The partnership launches the primary U.S. scientific pilot of EndomAI, Matricis.ai’s flagship AI platform designed to help radiologists in detecting endometriosis from MRI scans. The pilot comes at a pivotal second for the sphere, as latest ACOG scientific pointers acknowledge MRI as a key device within the endometriosis scientific pathway. The pilot additionally expands the corporate’s technological benefit constructed on one of many world’s largest proprietary annotated datasets in gynecological imaging.
Endometriosis is a situation that impacts 1 in 10 ladies of reproductive age worldwide. It’s a complicated illness that’s continuously underdiagnosed regardless of affecting hundreds of thousands of girls. Consequently, sufferers typically expertise lengthy delays between the onset of signs and a confirmed prognosis. Research recommend that the common time from symptom onset to prognosis ranges from 7-10 years, with almost 42% of girls reporting that their ache was initially dismissed as “normal.” Moreover, 30-50% of girls with endometriosis expertise fertility challenges, underscoring the necessity for earlier and extra dependable detection.
EndomAI goals to deal with these diagnostic challenges by:
Producing standardized reporting templates and structured outputs, Mapping the distribution and extent of lesions, aiding in surgical procedure planning, Offering choice help for follow-up care and specialist referrals.
Within the preliminary pilot section, sufferers with suspected or recognized endometriosis will bear an MRI scan at choose SimonMed facilities. The research will consider the impression of AI-assisted reporting on diagnostic consistency, lesion detection, and radiologist confidence when speaking findings to referring OB/GYN physicians. All imaging interpretations will stay underneath the supervision of SimonMed’s board-certified radiologists.
More Read
“A decade-long diagnostic delay for endometriosis is unacceptable in modern medicine, and AI has the potential to change that,” mentioned Raphaelle Taub, CEO and co-founder of Matricis.ai. “The latest ACOG guidelines, recognizing MRI as a key tool for characterizing endometriosis, mark an important turning point for the field. Our collaboration with SimonMed allows us to bring AI directly into clinical radiology workflows and accelerate the adoption of advanced imaging in women’s health.”
“March, Endometriosis Awareness Month, is an important reminder that 200 million of women still face years of uncertainty before receiving a diagnosis,” mentioned Taub. “Improving the clarity and consistency of imaging interpretation can help clinicians identify the disease earlier and give patients a clearer role in treatment decisions.”
“Endometriosis is a highly variable disease that often takes up to a decade to diagnose,” mentioned Dr. Sean Raj, Chief Medical Officer and Chief Innovation Officer of SimonMed. “With AI-supported MRI technologies like EndomAI, we hope to reduce that diagnostic time and increase confidence in image interpretation, all while providing referring physicians with clearer information for treatment planning.”
More Read
By partnering with one of many largest imaging networks in the USA, Matricis.ai goals to speed up the scientific validation and deployment of AI instruments designed to help radiologists and gynecologists in diagnosing complicated gynecological ailments.
This scientific pilot represents a key milestone within the scientific validation and business deployment of our know-how,” added Taub. “It validates our technology in one of the largest imaging networks in the United States and positions us to accelerate regulatory approval and commercial deployment.”
To be taught extra about Matricis.ai, go to matricis.ai.
To be taught extra about SimonMed, go to simonmed.com.
About Matricis.ai
Matricis.ai is a french healthcare know-how firm creating an AI platform centered on complicated gynecological ailments affecting ladies’s well being and fertility, together with endometriosis, adenomyosis, and fibroids.The corporate’s flagship product, EndomAI, makes use of deep studying to help radiologists in detecting, mapping, and characterizing endometriosis from MRI scans.
More Read
By embedding AI instantly into scientific radiology workflows, Matricis.ai goals to enhance diagnostic consistency, help surgical planning, and speed up affected person entry to specialised care, leveraging the world’s largest curated dataset of annotated gynecological photos, to allow earlier detection and extra customized remedy pathways.
About SimonMed
Headquartered in Scottsdale, Arizona, SimonMed is likely one of the largest outpatient diagnostic imaging and well being know-how suppliers in the USA. SimonMed operates greater than 170 facilities throughout 10 states and is supported by a nationwide workforce of greater than 300 subspecialty-trained, board-certified radiologists. SimonMed gives the total spectrum of diagnostic imaging companies from X-ray to complicated Cardiac MRI and is a acknowledged chief within the scientific use of synthetic intelligence.
SimonMed Longevity is a division centered on proactive well being. It affords whole-body MRI and preventive, multi-modality screening designed to assist sufferers set up a baseline of their well being, observe modifications over time, and establish potential threat earlier—when knowledgeable motion might assist stop or delay illness.
Press Inquiries
Raphaelle Taubcontact [at] matricis.aihttps://matricis.ai
